Notably, we found that in our cohort there was a highly significant dose–response risk reduction among serum bicarbonate trajectories and the predefined composite renal endpoint.
← all excerpts
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model.
1
—
—